Mercer Global Advisors Inc. ADV Has $3.10 Million Stock Holdings in Maximus, Inc. (NYSE:MMS)

Mercer Global Advisors Inc. ADV decreased its holdings in shares of Maximus, Inc. (NYSE:MMS) by 3.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 36,120 shares of the health services provider’s stock after selling 1,347 shares during the quarter. Mercer Global Advisors Inc. ADV owned approximately 0.06% of Maximus worth $3,095,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Rise Advisors LLC increased its position in Maximus by 1,445.0% during the first quarter. Rise Advisors LLC now owns 309 shares of the health services provider’s stock worth $26,000 after buying an additional 289 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Maximus by 224.5% during the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock worth $29,000 after acquiring an additional 238 shares in the last quarter. Blue Trust Inc. increased its holdings in shares of Maximus by 201.5% during the 2nd quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock valued at $33,000 after acquiring an additional 262 shares during the last quarter. Kapitalo Investimentos Ltda bought a new position in shares of Maximus in the 4th quarter valued at approximately $52,000. Finally, Archer Investment Corp lifted its holdings in Maximus by 8,788.9% in the 2nd quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock worth $69,000 after purchasing an additional 791 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Maximus Trading Down 0.6 %

Shares of MMS stock opened at $89.98 on Monday. Maximus, Inc. has a 12 month low of $72.39 and a 12 month high of $93.97. The company has a market cap of $5.47 billion, a PE ratio of 23.62 and a beta of 0.76. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.61. The business’s 50 day moving average is $89.80 and its two-hundred day moving average is $86.15.

Maximus (NYSE:MMS) last posted its earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.27. The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.59% and a return on equity of 20.91%. Maximus’s revenue was up 10.6% compared to the same quarter last year. During the same period last year, the business posted $0.78 EPS. Equities analysts predict that Maximus, Inc. will post 6.12 EPS for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date was Thursday, August 15th. Maximus’s dividend payout ratio (DPR) is currently 31.50%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.